Willow Biosciences Stock Buy Hold or Sell Recommendation
| WLLW Stock | CAD 0.09 0.01 6.25% |
Assuming the 90 days trading horizon and your typical level of risk aversion, our recommendation regarding Willow Biosciences is 'Not Rated'. The recommendation algorithm takes into account all of Willow Biosciences' available fundamental, technical, and predictive indicators you will find on this site.
Check out Willow Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Willow and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Willow Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Willow |
Execute Willow Biosciences Buy or Sell Advice
The Willow recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Willow Biosciences. Macroaxis does not own or have any residual interests in Willow Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Willow Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Willow Biosciences Trading Alerts and Improvement Suggestions
| Willow Biosciences generated a negative expected return over the last 90 days | |
| Willow Biosciences has high historical volatility and very poor performance | |
| Willow Biosciences has some characteristics of a very speculative penny stock | |
| Willow Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 1.17 M. Net Loss for the year was (13.03 M) with profit before overhead, payroll, taxes, and interest of 821 K. | |
| Willow Biosciences has accumulated about 11.01 M in cash with (10.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 24.0% of the company outstanding shares are owned by insiders | |
| Latest headline from news.google.com: Willow Biosciences Launches 2M Private Placement - TipRanks |
Willow Biosciences Returns Distribution Density
The distribution of Willow Biosciences' historical returns is an attempt to chart the uncertainty of Willow Biosciences' future price movements. The chart of the probability distribution of Willow Biosciences daily returns describes the distribution of returns around its average expected value. We use Willow Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Willow Biosciences returns is essential to provide solid investment advice for Willow Biosciences.
| Mean Return | -0.03 | Value At Risk | -9.09 | Potential Upside | 6.25 | Standard Deviation | 5.29 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Willow Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Willow Biosciences Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Free Cash Flow | (15.9M) | (13.8M) | (20.0M) | (14.5M) | (11.5M) | (11.0M) | |
| Other Non Cash Items | 32.6M | 40K | 27K | (3.3M) | 80K | 76K | |
| Capital Expenditures | 6.7M | 997K | 1.8M | 682K | 619K | 642.1K | |
| Net Income | (44.6M) | (33.9M) | (6.1M) | (14.8M) | (13.0M) | (12.4M) | |
| Change In Cash | 19.3M | (3.7M) | 14.2M | (19.1M) | (7.9M) | (7.5M) | |
| End Period Cash Flow | 19.6M | 15.9M | 30.1M | 11.0M | 3.1M | 3.8M | |
| Depreciation | 2.2M | 3.2M | 3.2M | 2.6M | 1.8M | 1.9M | |
| Net Borrowings | (493K) | (651K) | (637K) | (723K) | (650.7K) | (618.2K) | |
| Change To Netincome | 33.6M | 18.2M | (15.0M) | (1.8M) | (1.6M) | (1.6M) |
Willow Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Willow Biosciences or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Willow Biosciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Willow stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.16 | |
β | Beta against Dow Jones | 0.94 | |
σ | Overall volatility | 5.33 | |
Ir | Information ratio | -0.03 |
Willow Biosciences Volatility Alert
Willow Biosciences exhibits very low volatility with skewness of -0.15 and kurtosis of 1.09. Willow Biosciences is a penny stock. Although Willow Biosciences may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Willow Biosciences. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Willow instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Willow Biosciences Fundamentals Vs Peers
Comparing Willow Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Willow Biosciences' direct or indirect competition across all of the common fundamentals between Willow Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Willow Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Willow Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Willow Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Willow Biosciences to competition |
| Fundamentals | Willow Biosciences | Peer Average |
| Return On Equity | -2.12 | -0.31 |
| Return On Asset | -0.75 | -0.14 |
| Operating Margin | (1.41) % | (5.51) % |
| Current Valuation | 13.16 M | 16.62 B |
| Shares Outstanding | 144.2 M | 571.82 M |
| Shares Owned By Insiders | 24.30 % | 10.09 % |
| Number Of Shares Shorted | 120.38 K | 4.71 M |
| Price To Earning | 4.00 X | 28.72 X |
| Price To Book | 62.86 X | 9.51 X |
| Price To Sales | 6.66 X | 11.42 X |
| Revenue | 1.17 M | 9.43 B |
| Gross Profit | 821 K | 27.38 B |
| EBITDA | (11.63 M) | 3.9 B |
| Net Income | (13.03 M) | 570.98 M |
| Cash And Equivalents | 11.01 M | 2.7 B |
| Cash Per Share | 0.19 X | 5.01 X |
| Total Debt | 2.16 M | 5.32 B |
| Debt To Equity | 0.02 % | 48.70 % |
| Current Ratio | 16.20 X | 2.16 X |
| Book Value Per Share | 0.03 X | 1.93 K |
| Cash Flow From Operations | (10.92 M) | 971.22 M |
| Short Ratio | 0.09 X | 4.00 X |
| Earnings Per Share | (0.05) X | 3.12 X |
| Target Price | 2.0 | |
| Number Of Employees | 19 | 18.84 K |
| Beta | 1.14 | -0.15 |
| Market Capitalization | 12.26 M | 19.03 B |
| Total Asset | 6.67 M | 29.47 B |
| Retained Earnings | (121.69 M) | 9.33 B |
| Working Capital | 2.36 M | 1.48 B |
| Net Asset | 6.67 M |
Willow Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Willow . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.06 | |||
| Day Median Price | 0.085 | |||
| Day Typical Price | 0.085 | |||
| Price Action Indicator | 0.0025 | |||
| Period Momentum Indicator | 0.005 |
About Willow Biosciences Buy or Sell Advice
When is the right time to buy or sell Willow Biosciences? Buying financial instruments such as Willow Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Willow Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Emerging Markets Funds Thematic Idea Now
Emerging Markets Funds
Fund or Etfs that invest in markets of developing countries. The Emerging Markets Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Emerging Markets Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Willow Stock
Willow Biosciences financial ratios help investors to determine whether Willow Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Willow with respect to the benefits of owning Willow Biosciences security.